This post was just published on ZYX Short Change Alert.
NPSP is a pharma company that is running up on rumors that Shire will by it. In all likelihood these rumors are false. Consider a 20% tranche in the zone of $33.50 to $34.85. The stock is at $34.31 as of this writing but is very volatile and your price may be different. It is suitable only for those who can withstand the risk if we are wrong and there really is a buy out.
Target zone is $27 to $30.50. Stops zone is $36.55 to $36.85. However please be aware that the stop may not be effective as the stock can gap up through the stop. For this reason, consider adjusting the quantity to your risk preference.
